Related Experiment Video
Updated: Jun 19, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
The Effect of Restrictive vs Liberal Blood Transfusion Strategy on Subsequent Myocardial Infarction Type
Andrew P DeFilippis1, J Dawn Abbott2, Brandon M Herbert3
1Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Insights
Among patients with myocardial infarction (MI) and anemia, type 2 MI occurred three times more often than type 1 MI within 30 days. Transfusion strategies did not show a differential impact on subsequent MI type.
Area of Science:
- Cardiology
- Clinical Trials
- Transfusion Medicine
Background:
- Limited data exist on how different interventions affect subsequent myocardial infarction (MI) types.
- Understanding these differences is crucial for optimizing patient care following an initial MI.
Purpose of the Study:
- To evaluate the 30-day rate of subsequent MI, specifically differentiating between type 1 and type 2 MI.
- To assess the impact of transfusion strategies (restrictive vs. liberal) on the type of subsequent MI in the MINT trial.
Main Methods:
- A post-hoc analysis of the MINT trial (NCT02981407) involving 3,504 patients.
- Fine-Gray subdistribution models were used to compute cumulative incidences and subdistribution hazard ratios for subsequent MI types, accounting for competing risks.
- Log-binomial regression models tested for effect modification by index MI type on treatment strategy.
Main Results:
- Overall, 7.8% of patients experienced a 30-day subsequent MI.
- Type 2 MI was the most common subsequent MI type (43%), followed by uncertain MI type (28%), type 4 MI (15%), and type 1 MI (14%).
- No significant difference was observed in the rates of subsequent type 1 MI (1.3% vs. 0.9%) or type 2 MI (3.5% vs. 3.2%) between restrictive and liberal transfusion strategies.
Conclusions:
- In patients with MI and anemia, subsequent MIs occur within 30 days in 7.8% of cases.
- Type 2 MI is significantly more frequent (3x) than type 1 MI among these patients.
- The transfusion strategy (restrictive vs. liberal) did not differentially affect the type of subsequent MI observed.
Background:
Data on the differential impact of interventions on subsequent myocardial infarction (MI) type are limited.
Objectives:
This post-hoc analysis was done to evaluate the 30-day rate of subsequent MI by type (ie, type 1 and 2) among patients enrolled in the MINT (Myocardial Ischemia and Transfusion; NCT02981407) trial.
Methods:
Subdistribution HRs and cumulative incidences of subsequent MI types were computed using Fine-Gray subdistribution models that accounted for the competing risk of death and other MI types, if applicable. Effect modification of treatment strategy by index MI type was tested using log-binomial regression models.
Results:
Among 3,504 MINT trial patients, 275 (7.8%) had a 30-day subsequent MI, of which 118 (43%) were type 2 MI, 79 (28%) were uncertain MI type, 40 (15%) were type 4 MI, and 38 (14%) were type 1 MI. The rate of subsequent type 2 MI in patients randomized to the restrictive vs liberal transfusion was 3.5% (n = 61) vs 3.2% (n = 57) (HR: 1.07; 95% CI: 0.74-1.53) as compared with a subsequent type 1 MI rate of 1.3% (n = 23) vs 0.9% (n = 15) (HR: 1.53; 95% CI: 0.80-2.94).
Conclusions:
Among patients with MI and anemia, subsequent MI occurred within 30 days in 7.8% of patients, with type 2 MI occurring 3 times more often than type 1 MI. A differential effect of the restrictive vs liberal transfusion strategy on the type of subsequent MI (eg, type 1 vs type 2) was not observed.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...